Dulis, Dionelia T.
HRN: 24-24-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFTAZIDIME 1GM (VIAL)
12/12/2023
12/18/2023
IVT
1g
Q8
Cellulitis Bilateral Leg
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes